JD Health International (HKG:6618) recorded a 4.6% rise in attributable profit in the first quarter to 934.4 million yuan from 893.4 million yuan a year prior, a Tuesday filing with the Hong Kong bourse said.
The firm's revenue rose 26% in the three months to 16.6 billion yuan from 13.3 billion yuan previously.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.